September 27, 2017 09:25 AM EDTUpdated 10:16 AM
People

Small is big: Phar­ma’s R&D brain drain con­tin­ues as GSK’s Chris Car­pen­ter jumps to up­start Ru­bius

John Carroll

Editor & Founder

The steady mi­gra­tion of top R&D ex­ecs out of Big Phar­ma and in­to lit­tle biotech is con­tin­u­ing this morn­ing.

Af­ter spend­ing the last decade in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times